• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从啮齿动物到人:阿尔茨海默病中错误折叠蛋白 tau 的神秘中间神经元迁徙。

Of rodents and men: the mysterious interneuronal pilgrimage of misfolded protein tau in Alzheimer’s disease.

机构信息

The Institute of Neuroimmunology, Slovak Academy of Sciences, Bratislava, Slovakia.

出版信息

J Alzheimers Dis. 2013;37(3):569-77. doi: 10.3233/JAD-131106.

DOI:10.3233/JAD-131106
PMID:23948940
Abstract

Neurofibrillary degeneration, driven by misfolded protein tau, spreads from the predisposed induction sites and advances in a topographically predictable sequence along connected brain areas. Several mouse model studies have demonstrated that some species of pathologically modified tau, namely insoluble fibrils and soluble oligomers, evoke propagation of the pathology. These results clearly show that the spreading potency of misfolded tau does not depend exclusively on its solubility and/or mutations. The candidate factor responsible for the progression of misfolded protein tau is its disease modified conformation. In this study, we address the question, whether insoluble tau complexes containing either 3R or 4R human misfolded truncated tau (AlzTau) command distinct infectivity and spreading potency. We found that insoluble tau isolated from transgenic rats (SHR24), expressing misfolded 3R AlzTau, was able to infect cortical neurons in the area of injection in SHR72 transgenic rats expressing 4R AlzTau. However this tau was not able to spread into other brain areas. In contrast, administration of insoluble tau isolated from SHR72 transgenic rats was not only able to infect cortical neurons but also induced extensive spreading of neurofibrillary tangles in the adjacent brain areas. These findings suggest the existence of various strains of disease modified tau, tauons displaying different infectivity and spreading potency. Furthermore, the presented rat tauopathy models could serve as a tool for identification and characterization of tauons isolated from Alzheimer's disease brains that would allow stratification of Alzheimer's disease patients.

摘要

神经原纤维缠结,由错误折叠的蛋白 tau 驱动,从易感性诱导部位开始扩散,并沿着连通的脑区以地形上可预测的顺序前进。几项小鼠模型研究表明,某些病理修饰的 tau 物种,即不溶性纤维和可溶性寡聚物,会引发病理学的传播。这些结果清楚地表明,错误折叠 tau 的扩散能力不仅取决于其溶解度和/或突变。导致错误折叠蛋白 tau 进展的候选因素是其疾病修饰构象。在这项研究中,我们探讨了这样一个问题,即是否含有 3R 或 4R 人错误折叠截断 tau(AlzTau)的不溶性 tau 复合物具有不同的感染力和扩散能力。我们发现,从表达错误折叠 3R AlzTau 的转基因大鼠(SHR24)中分离出的不溶性 tau 能够感染在表达 4R AlzTau 的 SHR72 转基因大鼠的注射区域中的皮质神经元。然而,这种 tau 不能扩散到其他脑区。相比之下,从 SHR72 转基因大鼠中分离出的不溶性 tau 不仅能够感染皮质神经元,而且还能诱导相邻脑区神经纤维缠结的广泛扩散。这些发现表明存在各种疾病修饰的 tau 株,tauons 显示出不同的感染力和扩散能力。此外,所提出的大鼠 tau 病模型可以作为从阿尔茨海默病大脑中分离出的 tauons 的鉴定和特征描述的工具,从而允许对阿尔茨海默病患者进行分层。

相似文献

1
Of rodents and men: the mysterious interneuronal pilgrimage of misfolded protein tau in Alzheimer’s disease.从啮齿动物到人:阿尔茨海默病中错误折叠蛋白 tau 的神秘中间神经元迁徙。
J Alzheimers Dis. 2013;37(3):569-77. doi: 10.3233/JAD-131106.
2
Truncated tau expression levels determine life span of a rat model of tauopathy without causing neuronal loss or correlating with terminal neurofibrillary tangle load.截短的tau蛋白表达水平决定了tau蛋白病大鼠模型的寿命,而不会导致神经元丢失,也与终末期神经原纤维缠结负荷无关。
Eur J Neurosci. 2008 Jul;28(2):239-46. doi: 10.1111/j.1460-9568.2008.06329.x.
3
First transgenic rat model developing progressive cortical neurofibrillary tangles.首例进展性皮质神经原纤维缠结的转基因大鼠模型。
Neurobiol Aging. 2012 Jul;33(7):1448-56. doi: 10.1016/j.neurobiolaging.2010.10.015. Epub 2010 Dec 31.
4
First-in-Rat Study of Human Alzheimer's Disease Tau Propagation.首例在大鼠中进行的人类阿尔茨海默病 Tau 蛋白传播研究。
Mol Neurobiol. 2019 Jan;56(1):621-631. doi: 10.1007/s12035-018-1102-0. Epub 2018 May 16.
5
Immunomodulation of memory-impairing protein tau in Alzheimer's disease.阿尔茨海默病中导致记忆障碍的蛋白 tau 的免疫调节。
Neurodegener Dis. 2012;10(1-4):242-5. doi: 10.1159/000333125. Epub 2012 Mar 13.
6
Spreading of tau pathology in Alzheimer's disease by cell-to-cell transmission.阿尔茨海默病中 tau 蛋白病理的细胞间传播。
Eur J Neurosci. 2013 Jun;37(12):1939-48. doi: 10.1111/ejn.12229.
7
Genetic background modifies neurodegeneration and neuroinflammation driven by misfolded human tau protein in rat model of tauopathy: implication for immunomodulatory approach to Alzheimer's disease.遗传背景改变了由错误折叠的人类 tau 蛋白驱动的神经退行性变和神经炎症在 tau 病大鼠模型中的作用:对阿尔茨海默病免疫调节方法的启示。
J Neuroinflammation. 2010 Oct 12;7:64. doi: 10.1186/1742-2094-7-64.
8
A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.一种由天然启动子驱动表达双突变tau的新型转基因小鼠表现出tau蛋白病特征。
Exp Neurol. 2008 Jul;212(1):71-84. doi: 10.1016/j.expneurol.2008.03.007. Epub 2008 Mar 21.
9
Minimalistic in vitro systems for investigating tau pathology.用于研究 tau 病理学的简约体外系统。
J Neurosci Methods. 2019 May 1;319:69-76. doi: 10.1016/j.jneumeth.2018.09.032. Epub 2018 Sep 29.
10
A NH2 tau fragment targets neuronal mitochondria at AD synapses: possible implications for neurodegeneration.AD 突触处的一个 NH2 端 tau 片段靶向神经元线粒体:可能对神经退行性变的影响。
J Alzheimers Dis. 2010;21(2):445-70. doi: 10.3233/JAD-2010-100120.

引用本文的文献

1
Shaping the future of preclinical development of successful disease-modifying drugs against Alzheimer's disease: a systematic review of tau propagation models.塑造成功治疗阿尔茨海默病的疾病修饰药物的临床前开发的未来:tau 传播模型的系统评价。
Acta Neuropathol Commun. 2024 Apr 4;12(1):52. doi: 10.1186/s40478-024-01748-5.
2
Methods for Biochemical Isolation of Insoluble Tau in Rodent Models of Tauopathies.用于 Tau 病鼠模型中不溶性 Tau 的生化分离的方法。
Methods Mol Biol. 2024;2754:323-341. doi: 10.1007/978-1-0716-3629-9_17.
3
Anterograde and Retrograde Propagation of Inoculated Human Tau Fibrils and Tau Oligomers in a Non-Transgenic Rat Tauopathy Model.
接种的人tau蛋白原纤维和tau蛋白寡聚体在非转基因大鼠tau蛋白病模型中的顺行和逆行传播
Biomedicines. 2023 Mar 24;11(4):1004. doi: 10.3390/biomedicines11041004.
4
Genetic Background Influences the Propagation of Tau Pathology in Transgenic Rodent Models of Tauopathy.遗传背景影响tau蛋白病转基因啮齿动物模型中tau病理的传播。
Front Aging Neurosci. 2019 Dec 11;11:343. doi: 10.3389/fnagi.2019.00343. eCollection 2019.
5
Therapeutic antibody targeting microtubule-binding domain prevents neuronal internalization of extracellular tau via masking neuron surface proteoglycans.靶向微管结合域的治疗性抗体通过掩盖神经元表面蛋白聚糖来防止细胞外 tau 的神经元内化。
Acta Neuropathol Commun. 2019 Aug 7;7(1):129. doi: 10.1186/s40478-019-0770-y.
6
Spreading of α-Synuclein and Tau: A Systematic Comparison of the Mechanisms Involved.α-突触核蛋白和 Tau 蛋白的传播:相关机制的系统比较
Front Mol Neurosci. 2019 Apr 25;12:107. doi: 10.3389/fnmol.2019.00107. eCollection 2019.
7
First-in-Rat Study of Human Alzheimer's Disease Tau Propagation.首例在大鼠中进行的人类阿尔茨海默病 Tau 蛋白传播研究。
Mol Neurobiol. 2019 Jan;56(1):621-631. doi: 10.1007/s12035-018-1102-0. Epub 2018 May 16.
8
The Neurotoxic Role of Extracellular Tau Protein.细胞外 Tau 蛋白的神经毒性作用。
Int J Mol Sci. 2018 Mar 27;19(4):998. doi: 10.3390/ijms19040998.
9
Down but Not Out: The Consequences of Pretangle Tau in the Locus Coeruleus.陷入困境但并未出局:蓝斑核中预纤维丝tau 的后果。
Neural Plast. 2017;2017:7829507. doi: 10.1155/2017/7829507. Epub 2017 Sep 5.